Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Analysis of early hypertension and clinical outcome with bevacizumab: results from seven phase III studies.

Analysis of early hypertension and clinical outcome with bevacizumab: results from seven phase III studies. Oncologist. 2013; 18(3):273-80.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.